Catalyst Wire Dossier Catalyst Wire Dossier

Hepsera (Adefovir dipivoxil)

Adefovir dipivoxil · Gilead Sciences
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Hepsera (Adefovir dipivoxil), covering 2016-04-01 to 2016-04-01. Get the full timeline:

Most recent: Clinical Trial Update: Switch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B Patients [Phase 4]

See pricing